These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22910)

  • 1. [Diabetes mellitus and the blood. I. Physiopathology of the erythrocytes in diabetes mellitus].
    Mincu I; Cheţa D
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1977; 29(4):289-96. PubMed ID: 22910
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study on erythrocyte oxygen dissociation activity in non-acidotic diabetic patients and their complications].
    Hosaki S; Okamura C; Hagiwara M; Suzumori K; Shiina S; Uchimura I; Maezawa H
    Rinsho Byori; 1986 Apr; 34(4):427-32. PubMed ID: 3747196
    [No Abstract]   [Full Text] [Related]  

  • 3. [Erythrocytic 2-3-diphosphoglycerate in diabetes mellitus].
    Giardina E; Triolo G; Contorno A; Rinaldi A
    Minerva Med; 1980 Jun; 71(24):1731-4. PubMed ID: 7413105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes of the oxygen release of the red cells in diabetics].
    Ditzel J; Andersen H; Peters ND
    Ugeskr Laeger; 1974 Apr; 136(15):812-4. PubMed ID: 4597392
    [No Abstract]   [Full Text] [Related]  

  • 5. [Adequate adjustment of diabetes mellitus decreases the possibility of diabetic complications].
    Wolffenbuttel BH; Huijberts MS; Heesen BJ; Leurs PB; Nieuwenhuijzen Kruseman AC
    Ned Tijdschr Geneeskd; 1993 Oct; 137(43):2179-83. PubMed ID: 8247161
    [No Abstract]   [Full Text] [Related]  

  • 6. Hemoglobin components in patients with diabetes mellitus.
    Trivelli LA; Ranney HM; Lai HT
    N Engl J Med; 1971 Feb; 284(7):353-7. PubMed ID: 5539916
    [No Abstract]   [Full Text] [Related]  

  • 7. [2,3-DPG and diabetic microangiopathy].
    Faure Nogueras E; Millastre Benito A; Blasco Comenge MC; García Alvarez F; Gutiérrez Martín M
    Rev Clin Esp; 1981 Nov; 163(4):227-30. PubMed ID: 7335930
    [No Abstract]   [Full Text] [Related]  

  • 8. [Glycosylated hemoglobins and erythrocyte 2,3-diphosphoglycerate in diabetes mellitus].
    Triolo G; Giardina E; Contorno A; Cipolla T; Giannuoli G; Caimi G; Catania A; Rinaldi A
    Arch Sci Med (Torino); 1981; 138(2):179-85. PubMed ID: 7018462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Quality of blood sugar control and late complications of diabetes].
    Sélam JL
    Rev Med Suisse Romande; 1995 Sep; 115(9):653-7. PubMed ID: 7481350
    [No Abstract]   [Full Text] [Related]  

  • 10. [Current status in the field of diabetes (review of the literature)].
    Stepanian-Tarakanova AM; Rubinshteĭn BN
    Vrach Delo; 1971 May; 5():83-9. PubMed ID: 4945980
    [No Abstract]   [Full Text] [Related]  

  • 11. [Metabolism of erythrocyte organic phosphates in diabetes mellitus with special reference to its vascular complication (author's transl)].
    Setoyama S; Kai M; Baba Y; Kamada T; Nishimoto H; Otsuji S
    Igaku Kenkyu; 1979 Sep; 49(3):326-32. PubMed ID: 161945
    [No Abstract]   [Full Text] [Related]  

  • 12. Abnormal hemorheology in diabetes mellitus.
    Barnes A; Locke P; Dormandy J; Dormandy T
    Bibl Anat; 1977; (16 Pt 2):428-9. PubMed ID: 603576
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diabetes control and late complications].
    Reitsma WD
    Ned Tijdschr Geneeskd; 1985 May; 129(21):989-93. PubMed ID: 3892314
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter: Increased haemoglobin A1c and 2,3-diphosphoglycerate in diabetes and their effects on red-cell oxygen-releasing capacity.
    Ditzel J; Andersen H; Peters ND
    Lancet; 1973 Nov; 302(7836):1034. PubMed ID: 4127262
    [No Abstract]   [Full Text] [Related]  

  • 15. [Particularities and practical aspects of the treatment and follow-up of diabetes mellitus in children].
    Dorchy H
    Journ Annu Diabetol Hotel Dieu; 1989; ():55-74. PubMed ID: 2668625
    [No Abstract]   [Full Text] [Related]  

  • 16. [Glycosylated hemoglobins. Their importance in the diabetic patient].
    Gajdos A
    Nouv Presse Med; 1979 Jul 14-28; 8(32):2613-6. PubMed ID: 493053
    [No Abstract]   [Full Text] [Related]  

  • 17. [Regulation of 2,3-diphosphoglycerate in erythrocytes of diabetic patients].
    Standl E; Kolb H; Mehnert H
    Verh Dtsch Ges Inn Med; 1973; 79():1191-4. PubMed ID: 4790134
    [No Abstract]   [Full Text] [Related]  

  • 18. The problems of tissue oxygenation in diabetes mellitus. III. The "three-in-one concept" for the development of diabetic microangiopathy and a rational approach to its prophylaxis.
    Ditzel J
    Acta Med Scand Suppl; 1975; 578():69-83. PubMed ID: 1057374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Maillard reaction products and chronic diabetic complications].
    Trivin F; Chevenne D; Hautecouverture M
    Ann Biol Clin (Paris); 1999; 57(4):445-54. PubMed ID: 10432367
    [No Abstract]   [Full Text] [Related]  

  • 20. [Erythrocyte 2,3-diphosphoglyceric acid content in diabetes mellitus].
    Bondar PN; Pristupiuk AM; Vostretsova OR
    Vrach Delo; 1981 Jan; (1):31-2. PubMed ID: 7210629
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.